Hyrimoz® (adalimumab-adaz)
for Ankylosing Spondylitis
Hyrimoz (adalimumab-adaz) is a biosimilar medication used to treat Crohn's disease in adults and children aged 6 or older. It is also prescribed for other conditions in adults, including uveitis, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and hidradenitis suppurativa. The drug works by blocking tumor necrosis factor (TNF), a chemical in the body involved in inflammation and immune responses.
